Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Diseases of the Thyroid

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 41 articles: HTML format

Single Articles

April 2008
1. GARSI JP , Schlumberger M, Rubino C, Ricard M, et al
   Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies.
   J Nucl Med. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. TUTTLE RM , Brokhin M, Omry G, Martorella AJ, et al
   Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal.
   J Nucl Med. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. KOOPMANS KP , de Groot JW, Plukker JT, de Vries EG, et al
   18F-Dihydroxyphenylalanine PET in Patients with Biochemical Evidence of Medullary Thyroid Cancer: Relation to Tumor Differentiation.
   J Nucl Med. 2008;49:524-531.
   PubMed     Related articles    Abstract available
   
   
   January 2008
4. MITTRA ES , Niederkohr RD, Rodriguez C, El-Maghraby T, et al
   Uncommon Causes of Thyrotoxicosis.
   J Nucl Med. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. BURNISTON MT , Wilson DJ
   Radioiodine ablation outcomes after imaging with 123I or 131I: is no news good news?
   J Nucl Med. 2008;49:166.
   PubMed     Related articles   
   
   
   September 2007
6. WALTER MA , Turtschi CP, Schindler C, Minnig P, et al
   The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study.
   J Nucl Med. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
7. AIDE N , Bardet S
   Would Patient Selection Based on Both Calcitonin Blood Level and Doubling Time Improve 18F-FDG PET Sensitivity in Restaging of Medullary Thyroid Cancer?
   J Nucl Med. 2007;48:1574.
   PubMed     Related articles   
   
   
   August 2007
8. KIM KI , Kang JH, Chung JK, Lee YJ, et al
   Doxorubicin Enhances the Expression of Transgene Under Control of the CMV Promoter in Anaplastic Thyroid Carcinoma Cells.
   J Nucl Med. 2007;.
   PubMed     Related articles    Abstract available
   
   
   
9. WALTER MA , Muller-Brand J, Muller B
   Antithyroid drugs and radioiodine and the absence of evidence.
   J Nucl Med. 2007;48:1403.
   PubMed     Related articles   
   
   
   June 2007
10. SILBERSTEIN EB
    Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
11. HANDKIEWICZ-JUNAK D , Wloch J, Roskosz J, Krajewska J, et al
    Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer.
    J Nucl Med. 2007;48:879-888.
    PubMed     Related articles    Abstract available
    
    
    
12. KARANTANIS D , Bogsrud TV, Wiseman GA, Mullan BP, et al
    Clinical Significance of Diffusely Increased 18F-FDG Uptake in the Thyroid Gland.
    J Nucl Med. 2007;48:896-901.
    PubMed     Related articles    Abstract available
    
    
    
13. ZITZMANN S , Kramer S, Mier W, Hebling U, et al
    Identification and evaluation of a new tumor cell-binding peptide, FROP-1.
    J Nucl Med. 2007;48:965-72.
    PubMed     Related articles    Abstract available
    
    
    May 2007
14. ITO S , Kato K, Ikeda M, Iwano S, et al
    Comparison of 18F-FDG PET and Bone Scintigraphy in Detection of Bone Metastases of Thyroid Cancer.
    J Nucl Med. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
15. HILDITCH TE , Bolster AA, Dempsey MF, Reed NS, et al
    Re: the so-called stunning of thyroid tissue.
    J Nucl Med. 2007;48:675-6.
    PubMed     Related articles   
    
    
    
16. ONG SC , Schoder H, Patel SG, Tabangay-Lim IM, et al
    Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels.
    J Nucl Med. 2007;48:501-507.
    PubMed     Related articles    Abstract available
    
    
    March 2007
17. IAGARU A , McDougall IR
    Treatment of thyrotoxicosis.
    J Nucl Med. 2007;48:379-89.
    PubMed     Related articles    Abstract available
    
    
    February 2007
18. GERARD SK , Park HM
    Stunning effect.
    J Nucl Med. 2007;48:328-9.
    PubMed     Related articles   
    
    
    
19. SHAMMAS A , Degirmenci B, Mountz JM, McCook BM, et al
    18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic Well-Differentiated Thyroid Cancer.
    J Nucl Med. 2007;48:221-226.
    PubMed     Related articles    Abstract available
    
    
    January 2007
20. QUON A , Fischbein NJ, McDougall IR, Le QT, et al
    Clinical Role of 18F-FDG PET/CT in the Management of Squamous Cell Carcinoma of the Head and Neck and Thyroid Carcinoma.
    J Nucl Med. 2007;48.
    PubMed     Related articles    Abstract available
    
    
    
21. KOLBERT KS , Pentlow KS, Pearson JR, Sheikh A, et al
    Prediction of Absorbed Dose to Normal Organs in Thyroid Cancer Patients Treated with 131I by Use of 124I PET and 3-Dimensional Internal Dosimetry Software.
    J Nucl Med. 2007;48:143-9.
    PubMed     Related articles    Abstract available
    
    
    
22. LASSMANN M , Hanscheid H
    Spatial dose mapping for individualizing radioiodine treatment.
    J Nucl Med. 2007;48:2-4.
    PubMed     Related articles   
    
    
    December 2006
23. SGOUROS G , Song H, Ladenson PW, Wahl RL, et al
    Lung Toxicity in Radioiodine Therapy of Thyroid Carcinoma: Development of a Dose-Rate Method and Dosimetric Implications of the 80-mCi Rule.
    J Nucl Med. 2006;47:1977-1984.
    PubMed     Related articles    Abstract available
    
    
    
24. SONG H , He B, Prideaux A, Du Y, et al
    Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    J Nucl Med. 2006;47:1985-94.
    PubMed     Related articles    Abstract available
    
    
    October 2006
25. TUTTLE RM , Leboeuf R, Robbins RJ, Qualey R, et al
    Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
    J Nucl Med. 2006;47:1587-91.
    PubMed     Related articles    Abstract available
    
    
    
26. TRAVIS CC , Stabin MG
    131I ablation treatment in young females after the Chernobyl accident.
    J Nucl Med. 2006;47:1723-7.
    PubMed     Related articles    Abstract available
    
    
    
27. REINERS C , Lassmann M, Hanscheid H
    A perspective on post-Chernobyl radioablation in young females.
    J Nucl Med. 2006;47:1563-4.
    PubMed     Related articles   
    
    
    September 2006
28. DE GEUS-OEI LF , Oyen WJ
    Reply: 18F-FDG PET of Thyroid Nodules with Inconclusive Cytologic Results.
    J Nucl Med. 2006;47:1555a-1556.
    PubMed     Related articles   
    
    
    
29. MARTINEZ-DUNCKER C , Hurtado-Lopez LM
    18F-FDG PET of Thyroid Nodules with Inconclusive Cytologic Results.
    J Nucl Med. 2006;47:1555.
    PubMed     Related articles   
    
    
    
30. SISSON JC , Avram AM, Lawson SA, Gauger PG, et al
    The so-called stunning of thyroid tissue.
    J Nucl Med. 2006;47:1406-12.
    PubMed     Related articles    Abstract available
    
    
    
31. WOOLFENDEN JM
    Thyroid stunning revisited.
    J Nucl Med. 2006;47:1403-5.
    PubMed     Related articles   
    
    
    August 2006
32. BLASER D , Maschauer S, Kuwert T, Prante O, et al
    In Vitro Studies on the Signal Transduction of Thyroidal Uptake of 18F-FDG and 131I-Iodide.
    J Nucl Med. 2006;47:1382-8.
    PubMed     Related articles    Abstract available
    
    
    
33. PRYMA DA , Schoder H, Gonen M, Robbins RJ, et al
    Diagnostic Accuracy and Prognostic Value of 18F-FDG PET in Hurthle Cell Thyroid Cancer Patients.
    J Nucl Med. 2006;47:1260-1266.
    PubMed     Related articles    Abstract available
    
    
    
34. LUBBERINK M , van Schie A, de Jong HW, van Dongen GA, et al
    Acquisition Settings for PET of 124I Administered Simultaneously with Therapeutic Amounts of 131I.
    J Nucl Med. 2006;47:1375-1381.
    PubMed     Related articles    Abstract available
    
    
    May 2006
35. CHEN L , Altmann A, Mier W, Eskerski H, et al
    Radioiodine Therapy of Hepatoma Using Targeted Transfer of the Human Sodium/Iodide Symporter Gene.
    J Nucl Med. 2006;47:854-862.
    PubMed     Related articles    Abstract available
    
    
    
36. DE GEUS-OEI LF , Pieters GF, Bonenkamp JJ, Mudde AH, et al
    18F-FDG PET Reduces Unnecessary Hemithyroidectomies for Thyroid Nodules with Inconclusive Cytologic Results.
    J Nucl Med. 2006;47:770-775.
    PubMed     Related articles    Abstract available
    
    
    April 2006
37. HANSCHEID H , Lassmann M, Luster M, Thomas SR, et al
    Iodine Biokinetics and Dosimetry in Radioiodine Therapy of Thyroid Cancer: Procedures and Results of a Prospective International Controlled Study of Ablation After rhTSH or Hormone Withdrawal.
    J Nucl Med. 2006;47:648-654.
    PubMed     Related articles    Abstract available
    
    
    
38. PALMEDO H , Bucerius J, Joe A, Strunk H, et al
    Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management.
    J Nucl Med. 2006;47:616-624.
    PubMed     Related articles    Abstract available
    
    
    
39. CHOI JY , Lee KS, Kim HJ, Shim YM, et al
    Focal Thyroid Lesions Incidentally Identified by Integrated 18F-FDG PET/CT: Clinical Significance and Improved Characterization.
    J Nucl Med. 2006;47:609-615.
    PubMed     Related articles    Abstract available
    
    
    March 2006
40. 
    Thyroid reports: insight into radioiodine ablation and new guidelines for nodule management.
    J Nucl Med. 2006;47:15N.
    PubMed     Related articles   
    
    
    February 2006
41. KRAEBER-BODERE F , Rousseau C, Bodet-Milin C, Ferrer L, et al
    Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
    J Nucl Med. 2006;47:247-55.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: